Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Reuters
Reuters
Health

Merck to buy $1 billion equity stake in Seattle Genetics

Merck & Co Inc said on Monday it would buy $1 billion worth of equity stake in Seattle Genetics's common stock.

The companies also said they would co-develop and sell Seattle Genetics's cancer therapy, ladiratuzumab vedotin. ( https://reut.rs/3bWTEvS)

(Reporting by Trisha Roy in Bengaluru; Editing by Rashmi Aich)

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.